Efficacy Test of a Moisturizing and Anti-aging Facial Mask

May 26, 2026 updated by: TCI Co., Ltd.

Efficacy Test of a Moisturizing and Anti-aging Facial Mask for Skin Improvement

The objective of this study is to evaluate the effect of Moisturizing facial mask and Anti-aging facial mask on human skin condition improvement.

Study Overview

Detailed Description

This study is a single-center, self-controlled human trial designed to evaluate the skin beauty effect of Moisturizing facial mask and Anti-aging facial mask.

Healthy adult participants aged above 18 years will be enrolled. Participants will be informed to apply the facial mask on whole face three times per week for 4 consecutive weeks. Skin measurement and self-assessment questionnaires will be conducted at baseline (before intake), after single use, and after continuous use for 2 and 4 weeks.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Pingdong, Taiwan
        • Chia Nan University of Pharmacy & Science

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Participants aged 18 years or older

Exclusion Criteria:

  • Non-voluntary participants.
  • Individuals diagnosed by a physician with skin diseases, liver cirrhosis, or chronic renal failure.
  • Individuals with known allergies to cosmetics, medications, or foods.
  • Pregnant or breastfeeding individuals.
  • Individuals taking medications for chronic diseases.
  • Students taught or supervised by the principal investigator.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Hydrating Repairing Mask
Applying the facial mask three times per week for a continuous period of 4 weeks
Other Names:
  • seibella Hydrating Repairing Mask
Experimental: Anti-aging Rejuvenating Mask
Applying the facial mask three times per week for a continuous period of 4 weeks
Other Names:
  • seibella Anti-aging Rejuvenating Mask

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The change of skin hydration
Time Frame: Change from Baseline skin hydration at 4 weeks
Corneometer® CM825 (CK, Germany) was utilized to measure skin surface hydation. Units: arbitrary Corneometer® units 0-120.
Change from Baseline skin hydration at 4 weeks
The change of skin redness
Time Frame: Change from Baseline skin redness at 4 weeks
Chroma Meter MM500 was utilized to measure face skin redness. Units: a* value
Change from Baseline skin redness at 4 weeks
The change of skin texture
Time Frame: Change from Baseline skin texture at 4 weeks
VISIA Complexion Analysis was utilized to measure skin texture. Units: arbitrary units
Change from Baseline skin texture at 4 weeks
The change of skin wrinkles
Time Frame: Change from Baseline skin wrinkles at 4 weeks
VISIA Complexion Analysis was utilized to measure skin wrinkles. Units: arbitrary units
Change from Baseline skin wrinkles at 4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The change of transepidermal water loss (TEWL)
Time Frame: Change from Baseline TEWL at 4 weeks
Tewameter® TM300 (CK, Germany) was utilized to measure TEWL. Units: g/hm²
Change from Baseline TEWL at 4 weeks
The change of skin tone
Time Frame: Change from Baseline skin tone at 4 weeks
Chroma Meter MM500 was utilized to measure face skin tone. Units: Individual Typology Angle (ITA°)
Change from Baseline skin tone at 4 weeks
The change of skin pores
Time Frame: Change from Baseline skin pores at 4 weeks
VISIA Complexion Analysis was utilized to measure skin pores. Units: arbitrary units
Change from Baseline skin pores at 4 weeks
The change of skin elasticity
Time Frame: Change from Baseline skin elasticity at 4 weeks
Skin elasticity (Softplus, Italy) was utilized to measure face skin elasticity. Units: arbitrary units
Change from Baseline skin elasticity at 4 weeks
The change of skin collagen density
Time Frame: Change from Baseline skin collagen density at 4 weeks
DermaLab® Series SkinLab Combo was utilized to measure skin collagen density. Units: arbitrary units
Change from Baseline skin collagen density at 4 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
The change of self-assessment skin condition
Time Frame: Change from Baseline skin condition at 4 weeks
Skin condition was evaluated using a 5-point Likert scale (0-4) to assess the severity of skin-related symptoms. The scale was defined as follows: 0 = none, 1 = mild, 2 = moderate, 3 = severe, and 4 = very severe.
Change from Baseline skin condition at 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Chia-Hua Liang, Ph.D., Chia Nan University of Pharmacy & Science

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 29, 2026

Primary Completion (Estimated)

June 15, 2026

Study Completion (Estimated)

July 31, 2026

Study Registration Dates

First Submitted

May 26, 2026

First Submitted That Met QC Criteria

May 26, 2026

First Posted (Actual)

June 3, 2026

Study Record Updates

Last Update Posted (Actual)

June 3, 2026

Last Update Submitted That Met QC Criteria

May 26, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • TMANH114-REC056

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Skin Condition

Clinical Trials on Hydrating Repairing Mask

Subscribe